These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17276739)

  • 1. MELAS and L-arginine therapy.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Katayama K; Matsuishi T
    Mitochondrion; 2007; 7(1-2):133-9. PubMed ID: 17276739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction in MELAS improved by l-arginine supplementation.
    Koga Y; Akita Y; Junko N; Yatsuga S; Povalko N; Fukiyama R; Ishii M; Matsuishi T
    Neurology; 2006 Jun; 66(11):1766-9. PubMed ID: 16769961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine is effective in stroke-like episodes of MELAS associated with the G13513A mutation.
    Shigemi R; Fukuda M; Suzuki Y; Morimoto T; Ishii E
    Brain Dev; 2011 Jun; 33(6):518-20. PubMed ID: 20832210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of L-arginine for stroke-like episode in MELAS.
    Kubota M; Sakakihara Y; Mori M; Yamagata T; Momoi-Yoshida M
    Brain Dev; 2004 Oct; 26(7):481-3; discussion 480. PubMed ID: 15351086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-arginine improves the symptoms of strokelike episodes in MELAS.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Tanabe Y; Fujimoto S; Matsuishi T
    Neurology; 2005 Feb; 64(4):710-2. PubMed ID: 15728297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox".
    Naini A; Kaufmann P; Shanske S; Engelstad K; De Vivo DC; Schon EA
    J Neurol Sci; 2005 Mar; 229-230():187-93. PubMed ID: 15760638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of MELAS and L-arginine effects.
    Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T
    Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.
    Koga Y; Povalko N; Nishioka J; Katayama K; Kakimoto N; Matsuishi T
    Ann N Y Acad Sci; 2010 Jul; 1201():104-10. PubMed ID: 20649546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.
    El-Hattab AW; Emrick LT; Chanprasert S; Craigen WJ; Scaglia F
    Int J Biochem Cell Biol; 2014 Mar; 48():85-91. PubMed ID: 24412347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient.
    Lekoubou A; Kouamé-Assouan AE; Cho TH; Luauté J; Nighoghossian N; Derex L
    Rev Neurol (Paris); 2011 Nov; 167(11):852-5. PubMed ID: 21514942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes].
    Sudo A; Sano H; Kawamura N
    No To Hattatsu; 2014 Jan; 46(1):39-43. PubMed ID: 24620430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome.
    Rodan LH; Poublanc J; Fisher JA; Sobczyk O; Mikulis DJ; Tein I
    PLoS One; 2020; 15(9):e0238224. PubMed ID: 32881886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiologic reversal of stroke-like episodes in MELAS with high-dose L-arginine.
    Siddiq I; Widjaja E; Tein I
    Neurology; 2015 Jul; 85(2):197-8. PubMed ID: 26070336
    [No Abstract]   [Full Text] [Related]  

  • 14. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders.
    El-Hattab AW; Emrick LT; Craigen WJ; Scaglia F
    Mol Genet Metab; 2012 Nov; 107(3):247-52. PubMed ID: 22819233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.
    Rodan LH; Wells GD; Banks L; Thompson S; Schneiderman JE; Tein I
    PLoS One; 2015; 10(5):e0127066. PubMed ID: 25993630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-arginine therapy on MELAS].
    Koga Y
    Rinsho Shinkeigaku; 2008 Nov; 48(11):1010-2. PubMed ID: 19198147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-arginine on the acute phase of strokes in three patients with MELAS.
    Koga Y; Ishibashi M; Ueki I; Yatsuga S; Fukiyama R; Akita Y; Matsuishi T
    Neurology; 2002 Mar; 58(5):827-8. PubMed ID: 11889254
    [No Abstract]   [Full Text] [Related]  

  • 18. Statin treatment improves cerebral more than systemic endothelial dysfunction in patients with arterial hypertension.
    Pretnar-Oblak J; Sebestjen M; Sabovic M
    Am J Hypertens; 2008 Jun; 21(6):674-8. PubMed ID: 18451811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [l-arginine efficiency in MELAS syndrome. A case report].
    Moutaouakil F; El Otmani H; Fadel H; Sefrioui F; Slassi I
    Rev Neurol (Paris); 2009 May; 165(5):482-5. PubMed ID: 18849057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research.
    Koga Y; Povalko N; Inoue E; Nakamura H; Ishii A; Suzuki Y; Yoneda M; Kanda F; Kubota M; Okada H; Fujii K
    J Neurol; 2018 Dec; 265(12):2861-2874. PubMed ID: 30269300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.